Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Invatec: medical device reports filed with FDA

1,071 reports name it as the manufacturer of the device involved, 2009–2024.

1,071
reports naming it as manufacturer
0% of all MAUDE reports
0
reports, 12 months to August 2026
1 in the 12 months before
45.2%
classified as malfunction
62.3% across all reports
6.1%
classified as death, as reported
0.9% across all reports

1,071 medical device reports received by FDA give Invatec as the manufacturer of the device involved, 0% of the MAUDE database, from May 2009 to December 2024. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, against 1 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (48.3%), malfunction (45.2%) and death (6.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Admiral XtremeCatheter, angioplasty, peripheral, transluminal13204.7%
Amphirion Deep Pta Balloon CatheterCatheter, percutaneous110017.4%
Pacific XtremeCatheter, angioplasty, peripheral, transluminal7704%
Pacific PlusCatheter, angioplasty, peripheral, transluminal5696.7%
Admiral Xtreme OtwCatheter, angioplasty, peripheral, transluminal27131%
Amphirion Deep OtwCatheter, percutaneous24160%
In Pact Admiral Paclitaxel-Eluting Pta Balloon CatheterDrug-eluting peripheral transluminal angioplasty catheter121046.5%
In Pact PacificDrug-eluting peripheral transluminal angioplasty catheter300%
Complete Se IliacStent, iliac205%
Fortrex 0 035 Otw Pta Balloon CatheterCatheter, angioplasty, peripheral, transluminal1290%
Spider FxTemporary carotid catheter for embolic capture1652%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
LITCatheter, angioplasty, peripheral, transluminal40337.6%
DQYCatheter, percutaneous26524.7%
NTETemporary carotid catheter for embolic capture25623.9%
FGEStents, drains and dilators for the biliary ducts999.2%
NIOStent, iliac171.6%
ONUDrug-eluting peripheral transluminal angioplasty catheter151.4%
DXECatheter, embolectomy111%
NIPStent, superficial femoral artery30.3%
DQXWire, guide, catheter10.1%

Reports by month, five years

023Sep 2021: 0Oct 2021: 0Nov 2021: 1Dec 2021: 22022Jan 2022: 1Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 1Jul 2022: 1Aug 2022: 1Sep 2022: 1Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 1Jun 2023: 1Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 12024Jan 2024: 0Feb 2024: 3Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 1Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 12025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death6.1%65
Injury48.3%517
Malfunction45.2%484
Other0.5%5
Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Invatec reports

How many FDA device reports name Invatec as manufacturer?

1,071 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Admiral Xtreme (132), Amphirion Deep Pta Balloon Catheter (110), Pacific Xtreme (77), Pacific Plus (56) and Admiral Xtreme Otw (27).

Which device types does it report on?

catheter, angioplasty, peripheral, transluminal (37.6%), catheter, percutaneous (24.7%), temporary carotid catheter for embolic capture (23.9%) and stents, drains and dilators for the biliary ducts (9.2%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.